

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.59991904 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.59991904 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.25657894 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.02895033 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.57046756 |
| 6 | detection of other organism (GO:0098543) | 4.53216151 |
| 7 | detection of bacterium (GO:0016045) | 4.47433606 |
| 8 | positive regulation of B cell differentiation (GO:0045579) | 4.32970334 |
| 9 | leukocyte aggregation (GO:0070486) | 4.18693934 |
| 10 | negative regulation of phagocytosis (GO:0050765) | 4.09967995 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 4.01377024 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.97753277 |
| 13 | regulation of B cell differentiation (GO:0045577) | 3.94678049 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 3.85437945 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.82807844 |
| 16 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.77821968 |
| 17 | detection of external biotic stimulus (GO:0098581) | 3.71796913 |
| 18 | respiratory burst (GO:0045730) | 3.70692899 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.67991985 |
| 20 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.63040263 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.61650278 |
| 22 | cellular extravasation (GO:0045123) | 3.58540947 |
| 23 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.57905261 |
| 24 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.54814907 |
| 25 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.54696978 |
| 26 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.54031137 |
| 27 | response to peptidoglycan (GO:0032494) | 3.53252422 |
| 28 | positive regulation by symbiont of host defense response (GO:0052509) | 3.50546140 |
| 29 | modulation by symbiont of host defense response (GO:0052031) | 3.50546140 |
| 30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.50546140 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.50546140 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.50546140 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 3.50546140 |
| 34 | regulation of leukocyte degranulation (GO:0043300) | 3.48070606 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.47604941 |
| 36 | response to host immune response (GO:0052572) | 3.47604941 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.46815307 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.46476373 |
| 39 | detection of biotic stimulus (GO:0009595) | 3.38924037 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.32836392 |
| 41 | regulation of tolerance induction (GO:0002643) | 3.32161119 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.31950461 |
| 43 | neutrophil activation (GO:0042119) | 3.31133464 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.30846566 |
| 45 | detection of molecule of bacterial origin (GO:0032490) | 3.28425959 |
| 46 | B cell receptor signaling pathway (GO:0050853) | 3.27987907 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.27140529 |
| 48 | B cell mediated immunity (GO:0019724) | 3.25858966 |
| 49 | response to host (GO:0075136) | 3.24737338 |
| 50 | response to host defenses (GO:0052200) | 3.24737338 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.24737338 |
| 52 | response to fungus (GO:0009620) | 3.23765600 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.22742591 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22413194 |
| 55 | T cell migration (GO:0072678) | 3.19451459 |
| 56 | cellular response to interleukin-15 (GO:0071350) | 3.17955292 |
| 57 | germinal center formation (GO:0002467) | 3.17717607 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 3.17358891 |
| 59 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.16283066 |
| 60 | T cell selection (GO:0045058) | 3.15937211 |
| 61 | microglial cell activation (GO:0001774) | 3.15039986 |
| 62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13818924 |
| 63 | macrophage activation (GO:0042116) | 3.10159410 |
| 64 | NIK/NF-kappaB signaling (GO:0038061) | 3.09155082 |
| 65 | positive regulation of mast cell degranulation (GO:0043306) | 3.08601771 |
| 66 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.08601771 |
| 67 | response to protozoan (GO:0001562) | 3.08232863 |
| 68 | negative regulation of granulocyte differentiation (GO:0030853) | 3.07955089 |
| 69 | granulocyte activation (GO:0036230) | 3.07869525 |
| 70 | regulation of antigen processing and presentation (GO:0002577) | 3.06693196 |
| 71 | thymic T cell selection (GO:0045061) | 3.06517775 |
| 72 | defense response to fungus (GO:0050832) | 3.06122621 |
| 73 | negative regulation of cell killing (GO:0031342) | 3.05847965 |
| 74 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.05847965 |
| 75 | defense response to protozoan (GO:0042832) | 3.05281381 |
| 76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04583553 |
| 77 | myeloid dendritic cell activation (GO:0001773) | 3.03379516 |
| 78 | positive T cell selection (GO:0043368) | 3.03331737 |
| 79 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03320690 |
| 80 | negative regulation of innate immune response (GO:0045824) | 3.02954029 |
| 81 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.01924039 |
| 82 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.01924039 |
| 83 | mast cell activation (GO:0045576) | 3.00403405 |
| 84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.97914594 |
| 85 | positive thymic T cell selection (GO:0045059) | 2.97833806 |
| 86 | cellular response to zinc ion (GO:0071294) | 2.97215536 |
| 87 | leukocyte degranulation (GO:0043299) | 2.96763502 |
| 88 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.96300238 |
| 89 | negative regulation of interleukin-6 production (GO:0032715) | 2.96218371 |
| 90 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.94267171 |
| 91 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.94267171 |
| 92 | response to type I interferon (GO:0034340) | 2.94121467 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 2.91592939 |
| 94 | definitive hemopoiesis (GO:0060216) | 2.91583643 |
| 95 | cellular response to type I interferon (GO:0071357) | 2.91396879 |
| 96 | type I interferon signaling pathway (GO:0060337) | 2.91396879 |
| 97 | regulation of regulated secretory pathway (GO:1903305) | 2.89554491 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.89097999 |
| 99 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87754912 |
| 100 | response to interferon-beta (GO:0035456) | 2.87641456 |
| 101 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86116145 |
| 102 | megakaryocyte development (GO:0035855) | 2.82610309 |
| 103 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81423734 |
| 104 | ribosomal small subunit assembly (GO:0000028) | 2.80962412 |
| 105 | angiogenesis involved in wound healing (GO:0060055) | 2.80673485 |
| 106 | leukocyte cell-cell adhesion (GO:0007159) | 2.80487559 |
| 107 | actin nucleation (GO:0045010) | 2.79455505 |
| 108 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79014131 |
| 109 | regulation of growth of symbiont in host (GO:0044126) | 2.78798889 |
| 110 | negative regulation of growth of symbiont in host (GO:0044130) | 2.78798889 |
| 111 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.78798889 |
| 112 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.78798889 |
| 113 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.78479276 |
| 114 | myeloid cell activation involved in immune response (GO:0002275) | 2.78426594 |
| 115 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.77806078 |
| 116 | macrophage activation involved in immune response (GO:0002281) | 2.77559062 |
| 117 | positive regulation of antigen processing and presentation (GO:0002579) | 2.77183790 |
| 118 | tolerance induction (GO:0002507) | 2.76763801 |
| 119 | regulation of interferon-alpha production (GO:0032647) | 2.76554094 |
| 120 | myeloid dendritic cell differentiation (GO:0043011) | 2.75568404 |
| 121 | positive regulation of mast cell activation (GO:0033005) | 2.73932172 |
| 122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73223179 |
| 123 | regulation of hypersensitivity (GO:0002883) | 2.72120352 |
| 124 | mature B cell differentiation (GO:0002335) | 2.69585282 |
| 125 | T cell homeostasis (GO:0043029) | 2.68662472 |
| 126 | regulation of mast cell activation (GO:0033003) | 2.68350880 |
| 127 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.68182518 |
| 128 | negative thymic T cell selection (GO:0045060) | 2.68175935 |
| 129 | response to interleukin-15 (GO:0070672) | 2.67776649 |
| 130 | regulation of mast cell degranulation (GO:0043304) | 2.66699160 |
| 131 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.65092772 |
| 132 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.64524616 |
| 133 | myeloid leukocyte mediated immunity (GO:0002444) | 2.62601974 |
| 134 | macrophage differentiation (GO:0030225) | 2.61408356 |
| 135 | pinocytosis (GO:0006907) | 2.60158682 |
| 136 | cellular response to interferon-beta (GO:0035458) | 2.58823340 |
| 137 | negative T cell selection (GO:0043383) | 2.57684511 |
| 138 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56123057 |
| 139 | regulation of necroptotic process (GO:0060544) | 2.55310329 |
| 140 | regulation of response to interferon-gamma (GO:0060330) | 2.55187604 |
| 141 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.54443560 |
| 142 | interferon-gamma production (GO:0032609) | 2.53524588 |
| 143 | lymphocyte homeostasis (GO:0002260) | 2.52636180 |
| 144 | natural killer cell differentiation (GO:0001779) | 2.48703612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.37853709 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.81512238 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.62939245 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.62677119 |
| 5 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.57003769 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.32243756 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.30654594 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.27969570 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.27306982 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.22005445 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.15799842 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.90959427 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.82979585 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.81395833 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72779829 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72107372 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71554131 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64731166 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63500074 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.43688928 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.40166740 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32138159 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28877274 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.27920652 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27640710 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.27460262 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.26505458 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.24346180 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08919693 |
| 30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.08916715 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.06312638 |
| 32 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01686581 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00007289 |
| 34 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.98303895 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97245191 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96606290 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.94324361 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79257959 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77080583 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.77067334 |
| 41 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76183362 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75512718 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72955375 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69208502 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66013067 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65964739 |
| 47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65754871 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56714644 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50064651 |
| 50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49482693 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.48452794 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47987960 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46065556 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41325777 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.40391879 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40290945 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39403654 |
| 58 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38854104 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34932090 |
| 60 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32566839 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32457362 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31864087 |
| 63 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29649960 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29469733 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29123526 |
| 66 | * STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28463902 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28028857 |
| 68 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27376910 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26825101 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26698560 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26052959 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25182119 |
| 73 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22847101 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20156437 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18485443 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16829697 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16581364 |
| 78 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13699164 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12101281 |
| 80 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.11799990 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10710532 |
| 82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09112050 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08581540 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07442979 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07233777 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07166737 |
| 87 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04790386 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04730806 |
| 89 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04628578 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04617414 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04027113 |
| 92 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04007964 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01909150 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99970618 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99247100 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98906364 |
| 97 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97469720 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97067568 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96885086 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95817616 |
| 101 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95027883 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94139498 |
| 103 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94062025 |
| 104 | P68_20966046_ChIP-Seq_HELA_Human | 0.92425319 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91931534 |
| 106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88879552 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86537967 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85496708 |
| 109 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85403846 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83493644 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82472902 |
| 112 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81741527 |
| 113 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.81714151 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80869029 |
| 115 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80023040 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79650375 |
| 117 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79466273 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79019748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.84290645 |
| 2 | MP0003436_decreased_susceptibility_to | 3.15501718 |
| 3 | MP0009785_altered_susceptibility_to | 2.99473002 |
| 4 | MP0003303_peritoneal_inflammation | 2.97197922 |
| 5 | MP0000685_abnormal_immune_system | 2.92831586 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.84682580 |
| 7 | MP0005671_abnormal_response_to | 2.83449556 |
| 8 | MP0001800_abnormal_humoral_immune | 2.72059681 |
| 9 | MP0002419_abnormal_innate_immunity | 2.70796577 |
| 10 | MP0005025_abnormal_response_to | 2.68008862 |
| 11 | MP0005387_immune_system_phenotype | 2.65263622 |
| 12 | MP0001790_abnormal_immune_system | 2.65263622 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.58879548 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.54295017 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.46271422 |
| 16 | MP0002723_abnormal_immune_serum | 2.41502102 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.41285554 |
| 18 | MP0001819_abnormal_immune_cell | 2.40369253 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.37773674 |
| 20 | MP0003724_increased_susceptibility_to | 2.35783571 |
| 21 | MP0002398_abnormal_bone_marrow | 2.19522356 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.14891879 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 2.14891879 |
| 24 | MP0001853_heart_inflammation | 2.14341733 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.13584679 |
| 26 | MP0009278_abnormal_bone_marrow | 2.13436416 |
| 27 | MP0002405_respiratory_system_inflammati | 2.10493872 |
| 28 | MP0000716_abnormal_immune_system | 2.02105567 |
| 29 | MP0003763_abnormal_thymus_physiology | 2.01331057 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.95211912 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.92731475 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.87884228 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.87694243 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.85052672 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.80564556 |
| 36 | MP0002722_abnormal_immune_system | 1.78761746 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.78307412 |
| 38 | MP0002429_abnormal_blood_cell | 1.75913694 |
| 39 | MP0001873_stomach_inflammation | 1.71045789 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.63128279 |
| 41 | MP0006082_CNS_inflammation | 1.62776558 |
| 42 | MP0004510_myositis | 1.61989832 |
| 43 | MP0008260_abnormal_autophagy | 1.60300803 |
| 44 | MP0002006_tumorigenesis | 1.56333350 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.53299830 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.53225243 |
| 47 | MP0008469_abnormal_protein_level | 1.49899845 |
| 48 | MP0004947_skin_inflammation | 1.49663831 |
| 49 | MP0005451_abnormal_body_composition | 1.44691052 |
| 50 | MP0000343_altered_response_to | 1.42227734 |
| 51 | MP0000858_altered_metastatic_potential | 1.39175538 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.35667413 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.34813558 |
| 54 | MP0000490_abnormal_crypts_of | 1.32773779 |
| 55 | MP0003866_abnormal_defecation | 1.26534444 |
| 56 | MP0009764_decreased_sensitivity_to | 1.25827036 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.21417466 |
| 58 | MP0003448_altered_tumor_morphology | 1.20884489 |
| 59 | MP0003828_pulmonary_edema | 1.19901008 |
| 60 | MP0009840_abnormal_foam_cell | 1.19388820 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.10452644 |
| 62 | MP0004381_abnormal_hair_follicle | 1.07027488 |
| 63 | MP0002933_joint_inflammation | 1.05705663 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.01412845 |
| 65 | MP0002019_abnormal_tumor_incidence | 0.99745353 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 0.98536585 |
| 67 | MP0001851_eye_inflammation | 0.98480599 |
| 68 | MP0003183_abnormal_peptide_metabolism | 0.98423106 |
| 69 | MP0010307_abnormal_tumor_latency | 0.97299013 |
| 70 | MP0000604_amyloidosis | 0.96182056 |
| 71 | MP0009763_increased_sensitivity_to | 0.95141712 |
| 72 | MP0005310_abnormal_salivary_gland | 0.94908764 |
| 73 | MP0003690_abnormal_glial_cell | 0.93758387 |
| 74 | MP0000249_abnormal_blood_vessel | 0.93654915 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 0.93417003 |
| 76 | MP0008057_abnormal_DNA_replication | 0.92079185 |
| 77 | MP0008004_abnormal_stomach_pH | 0.91946982 |
| 78 | MP0002132_abnormal_respiratory_system | 0.91516232 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.90468132 |
| 80 | MP0005164_abnormal_response_to | 0.89904489 |
| 81 | MP0003693_abnormal_embryo_hatching | 0.87565880 |
| 82 | MP0003075_altered_response_to | 0.84813236 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.84628696 |
| 84 | MP0006054_spinal_hemorrhage | 0.79957871 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.77486878 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.77376816 |
| 87 | MP0005023_abnormal_wound_healing | 0.76492928 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.75724768 |
| 89 | MP0005166_decreased_susceptibility_to | 0.75504025 |
| 90 | MP0000609_abnormal_liver_physiology | 0.75229808 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.74532164 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.74452830 |
| 93 | MP0003795_abnormal_bone_structure | 0.73927077 |
| 94 | MP0001663_abnormal_digestive_system | 0.72382524 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.72180362 |
| 96 | MP0003091_abnormal_cell_migration | 0.71251940 |
| 97 | MP0000598_abnormal_liver_morphology | 0.70388259 |
| 98 | MP0003077_abnormal_cell_cycle | 0.70043086 |
| 99 | MP0003045_fibrosis | 0.69966311 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.69190348 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.64449625 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.64047001 |
| 103 | MP0003943_abnormal_hepatobiliary_system | 0.63638988 |
| 104 | MP0004883_abnormal_blood_vessel | 0.63537671 |
| 105 | MP0003279_aneurysm | 0.63372410 |
| 106 | MP0008873_increased_physiological_sensi | 0.63218287 |
| 107 | MP0003186_abnormal_redox_activity | 0.62089623 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.61518663 |
| 109 | MP0005390_skeleton_phenotype | 0.61457778 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.60768998 |
| 111 | MP0000371_diluted_coat_color | 0.60667541 |
| 112 | MP0010094_abnormal_chromosome_stability | 0.60653402 |
| 113 | MP0002928_abnormal_bile_duct | 0.60430193 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.60364549 |
| 115 | MP0008874_decreased_physiological_sensi | 0.60191772 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.54479882 |
| 117 | MP0002009_preneoplasia | 0.52476351 |
| 118 | MP0001958_emphysema | 0.50318316 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.48793750 |
| 120 | MP0002254_reproductive_system_inflammat | 0.46504018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.51566000 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.17001706 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.02692593 |
| 4 | Myositis (HP:0100614) | 4.73259242 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.68174908 |
| 6 | Thrombocytosis (HP:0001894) | 4.16755808 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.11819142 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.07415383 |
| 9 | IgM deficiency (HP:0002850) | 4.01906521 |
| 10 | Recurrent viral infections (HP:0004429) | 3.83431330 |
| 11 | Chronic otitis media (HP:0000389) | 3.66322447 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.65707742 |
| 13 | Orchitis (HP:0100796) | 3.64817110 |
| 14 | Recurrent skin infections (HP:0001581) | 3.64623588 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.54483312 |
| 16 | Meningitis (HP:0001287) | 3.54179673 |
| 17 | Cellulitis (HP:0100658) | 3.42853106 |
| 18 | Petechiae (HP:0000967) | 3.40875010 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.35646887 |
| 20 | Optic neuritis (HP:0100653) | 3.35646887 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.35392128 |
| 22 | Obstructive lung disease (HP:0006536) | 3.35392128 |
| 23 | Prolonged bleeding time (HP:0003010) | 3.29279325 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.26703129 |
| 25 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.21602096 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.21602096 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.21602096 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.21455183 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.21455183 |
| 30 | Spontaneous hematomas (HP:0007420) | 3.19967137 |
| 31 | Vasculitis (HP:0002633) | 3.15899837 |
| 32 | Recurrent bronchitis (HP:0002837) | 3.07006938 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 3.02697959 |
| 34 | Epistaxis (HP:0000421) | 3.02609048 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.99152826 |
| 36 | Interstitial pulmonary disease (HP:0006530) | 2.95678265 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.95602794 |
| 38 | Arterial thrombosis (HP:0004420) | 2.92985399 |
| 39 | Gingival bleeding (HP:0000225) | 2.90874782 |
| 40 | Abnormal platelet function (HP:0011869) | 2.89513127 |
| 41 | Impaired platelet aggregation (HP:0003540) | 2.89513127 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 2.88483258 |
| 43 | Nasal polyposis (HP:0100582) | 2.88458524 |
| 44 | Periodontitis (HP:0000704) | 2.87439495 |
| 45 | Abnormality of the nasal mucosa (HP:0000433) | 2.86345055 |
| 46 | Chest pain (HP:0100749) | 2.82381005 |
| 47 | Colitis (HP:0002583) | 2.80811383 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.80007589 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.78911511 |
| 50 | Pustule (HP:0200039) | 2.76238755 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.74159221 |
| 52 | Hemoptysis (HP:0002105) | 2.68447564 |
| 53 | Episodic fever (HP:0001954) | 2.68261487 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.67182807 |
| 55 | Leukocytosis (HP:0001974) | 2.66006205 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.65625496 |
| 57 | Increased IgM level (HP:0003496) | 2.64555377 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.63274120 |
| 59 | Gingivitis (HP:0000230) | 2.61863507 |
| 60 | Abnormality of T cells (HP:0002843) | 2.58808176 |
| 61 | Amyloidosis (HP:0011034) | 2.57990809 |
| 62 | Loss of speech (HP:0002371) | 2.57006730 |
| 63 | Hypochromic anemia (HP:0001931) | 2.55646605 |
| 64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55553930 |
| 65 | Encephalitis (HP:0002383) | 2.52075923 |
| 66 | Abnormal platelet volume (HP:0011876) | 2.51727560 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.49361780 |
| 68 | Increased serum ferritin (HP:0003281) | 2.48868931 |
| 69 | Stomatitis (HP:0010280) | 2.48829453 |
| 70 | Lymphopenia (HP:0001888) | 2.46848402 |
| 71 | Abnormality of the fingertips (HP:0001211) | 2.44913189 |
| 72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.43450162 |
| 73 | Eosinophilia (HP:0001880) | 2.42603134 |
| 74 | Hypochromic microcytic anemia (HP:0004840) | 2.41952296 |
| 75 | Urticaria (HP:0001025) | 2.41104598 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.39869449 |
| 77 | Osteomyelitis (HP:0002754) | 2.37775140 |
| 78 | Abnormality of B cell number (HP:0010975) | 2.35659881 |
| 79 | B lymphocytopenia (HP:0010976) | 2.35659881 |
| 80 | Granulocytopenia (HP:0001913) | 2.34391470 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.32013617 |
| 82 | Abnormality of the prostate (HP:0008775) | 2.30311092 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.25479925 |
| 84 | Pulmonary embolism (HP:0002204) | 2.25215612 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.25141268 |
| 86 | Anorexia (HP:0002039) | 2.24145081 |
| 87 | Peritonitis (HP:0002586) | 2.21524543 |
| 88 | Hematochezia (HP:0002573) | 2.21164714 |
| 89 | Abnormality of eosinophils (HP:0001879) | 2.20775411 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.20321245 |
| 91 | Purpura (HP:0000979) | 2.20144667 |
| 92 | Thyroiditis (HP:0100646) | 2.16850288 |
| 93 | Skin ulcer (HP:0200042) | 2.16720941 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 2.16559434 |
| 95 | Menorrhagia (HP:0000132) | 2.15682679 |
| 96 | Abnormality of the pleura (HP:0002103) | 2.14416543 |
| 97 | T lymphocytopenia (HP:0005403) | 2.10605110 |
| 98 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10233220 |
| 99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10233220 |
| 100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10233220 |
| 101 | Abnormality of T cell number (HP:0011839) | 2.09674681 |
| 102 | Acute myeloid leukemia (HP:0004808) | 2.09597933 |
| 103 | Thoracic kyphosis (HP:0002942) | 2.09121574 |
| 104 | IgA deficiency (HP:0002720) | 2.08732668 |
| 105 | Systemic lupus erythematosus (HP:0002725) | 2.07033085 |
| 106 | Increased IgE level (HP:0003212) | 2.06991437 |
| 107 | Increased mean platelet volume (HP:0011877) | 2.05945397 |
| 108 | Restrictive lung disease (HP:0002091) | 2.03974932 |
| 109 | Fatigue (HP:0012378) | 2.02466238 |
| 110 | Recurrent pneumonia (HP:0006532) | 2.02213327 |
| 111 | Gangrene (HP:0100758) | 2.01986436 |
| 112 | Abnormality of the peritoneum (HP:0002585) | 2.01873731 |
| 113 | Glomerulopathy (HP:0100820) | 2.00751958 |
| 114 | Joint hemorrhage (HP:0005261) | 1.99403027 |
| 115 | Microcytic anemia (HP:0001935) | 1.98442438 |
| 116 | Thrombophlebitis (HP:0004418) | 1.98379473 |
| 117 | Premature loss of primary teeth (HP:0006323) | 1.97168866 |
| 118 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95011799 |
| 119 | Lymphoma (HP:0002665) | 1.94980317 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94433540 |
| 121 | Mucopolysacchariduria (HP:0008155) | 1.94433540 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 1.93654398 |
| 123 | Papilloma (HP:0012740) | 1.93323608 |
| 124 | Verrucae (HP:0200043) | 1.93323608 |
| 125 | IgG deficiency (HP:0004315) | 1.92461055 |
| 126 | Recurrent sinusitis (HP:0011108) | 1.91405305 |
| 127 | Sepsis (HP:0100806) | 1.90542624 |
| 128 | Albinism (HP:0001022) | 1.89983597 |
| 129 | Arthralgia (HP:0002829) | 1.89379453 |
| 130 | Aplastic anemia (HP:0001915) | 1.88945329 |
| 131 | Viral hepatitis (HP:0006562) | 1.88879027 |
| 132 | Abnormality of the thoracic spine (HP:0100711) | 1.88795779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.65378712 |
| 2 | PRPF4B | 2.84611609 |
| 3 | IRAK4 | 2.81574072 |
| 4 | KIT | 2.58362196 |
| 5 | TYK2 | 2.48415852 |
| 6 | BTK | 2.39564611 |
| 7 | IRAK3 | 2.38155226 |
| 8 | JAK3 | 2.35403625 |
| 9 | EEF2K | 2.29359837 |
| 10 | ERN1 | 2.23749036 |
| 11 | TXK | 2.22972049 |
| 12 | TBK1 | 2.18696712 |
| 13 | ZAP70 | 2.12749006 |
| 14 | BLK | 2.12076030 |
| 15 | TEC | 2.10597764 |
| 16 | TAOK3 | 2.08323112 |
| 17 | MAP3K14 | 1.99593612 |
| 18 | STK10 | 1.93465728 |
| 19 | MAP2K3 | 1.85951926 |
| 20 | CSF1R | 1.75301295 |
| 21 | IKBKE | 1.72355070 |
| 22 | RIPK4 | 1.71252697 |
| 23 | FLT3 | 1.69021365 |
| 24 | TGFBR2 | 1.67362683 |
| 25 | PIM2 | 1.58806239 |
| 26 | SYK | 1.55227783 |
| 27 | ITK | 1.53403889 |
| 28 | PKN2 | 1.49791307 |
| 29 | FES | 1.47874780 |
| 30 | KDR | 1.46456572 |
| 31 | LRRK2 | 1.44644996 |
| 32 | GRK6 | 1.43990668 |
| 33 | JAK1 | 1.42290174 |
| 34 | TRIB3 | 1.41885945 |
| 35 | IKBKB | 1.38221824 |
| 36 | PIM1 | 1.37760747 |
| 37 | EPHB1 | 1.37512311 |
| 38 | HCK | 1.36575759 |
| 39 | FGR | 1.33339509 |
| 40 | CSK | 1.30646225 |
| 41 | MAP3K10 | 1.26241645 |
| 42 | TAOK2 | 1.21472384 |
| 43 | MAP3K1 | 1.20922760 |
| 44 | RPS6KA4 | 1.17438220 |
| 45 | LCK | 1.16582100 |
| 46 | NME2 | 1.11651372 |
| 47 | CLK1 | 1.11111049 |
| 48 | LYN | 1.08924100 |
| 49 | PRKD2 | 1.05911306 |
| 50 | MARK2 | 1.02218405 |
| 51 | SMG1 | 0.98129876 |
| 52 | FGFR4 | 0.96054045 |
| 53 | TRPM7 | 0.93420478 |
| 54 | CHUK | 0.93116581 |
| 55 | CDC42BPA | 0.92434119 |
| 56 | PAK4 | 0.91924097 |
| 57 | MATK | 0.91877129 |
| 58 | JAK2 | 0.90741614 |
| 59 | SIK2 | 0.84856816 |
| 60 | BMPR2 | 0.83532587 |
| 61 | TIE1 | 0.80237661 |
| 62 | MAPK7 | 0.78845037 |
| 63 | MAP3K13 | 0.77528200 |
| 64 | PTK6 | 0.76058978 |
| 65 | TTN | 0.75495002 |
| 66 | NLK | 0.75000774 |
| 67 | IRAK1 | 0.72895361 |
| 68 | HIPK2 | 0.71951813 |
| 69 | RPS6KB2 | 0.71507777 |
| 70 | MARK3 | 0.71078485 |
| 71 | MAP3K11 | 0.70960402 |
| 72 | PDPK1 | 0.69433810 |
| 73 | NEK9 | 0.68533769 |
| 74 | CDK4 | 0.68406571 |
| 75 | IRAK2 | 0.68394374 |
| 76 | SIK3 | 0.68358300 |
| 77 | STK4 | 0.67455847 |
| 78 | MAP3K12 | 0.67127506 |
| 79 | KSR2 | 0.66751777 |
| 80 | GRK7 | 0.64664439 |
| 81 | MAPKAPK3 | 0.64490302 |
| 82 | MAPK4 | 0.63532464 |
| 83 | NEK2 | 0.62156446 |
| 84 | FGFR3 | 0.61805628 |
| 85 | TGFBR1 | 0.61369561 |
| 86 | RPS6KA6 | 0.61137741 |
| 87 | CDK12 | 0.60363458 |
| 88 | MAP3K8 | 0.60192721 |
| 89 | CDK6 | 0.57145006 |
| 90 | FYN | 0.56817901 |
| 91 | MAPK11 | 0.55125928 |
| 92 | CAMKK1 | 0.54924943 |
| 93 | RIPK1 | 0.52502257 |
| 94 | YES1 | 0.51789672 |
| 95 | RPS6KC1 | 0.50651557 |
| 96 | RPS6KL1 | 0.50651557 |
| 97 | PRKG2 | 0.49882647 |
| 98 | MAPKAPK2 | 0.49592686 |
| 99 | MAP2K2 | 0.49078629 |
| 100 | BCKDK | 0.47724461 |
| 101 | CAMK1D | 0.47609933 |
| 102 | TESK2 | 0.44801694 |
| 103 | PIK3CG | 0.43111152 |
| 104 | ABL1 | 0.42987211 |
| 105 | MAP3K3 | 0.42610121 |
| 106 | SIK1 | 0.42606950 |
| 107 | DYRK1B | 0.42251817 |
| 108 | MAP3K5 | 0.41541540 |
| 109 | CAMKK2 | 0.41323530 |
| 110 | CDK7 | 0.40224869 |
| 111 | EIF2AK3 | 0.40161664 |
| 112 | MOS | 0.38387678 |
| 113 | TNK2 | 0.37653763 |
| 114 | PTK2B | 0.36740365 |
| 115 | MAP3K7 | 0.35827172 |
| 116 | EPHA3 | 0.34867593 |
| 117 | PDK1 | 0.34841889 |
| 118 | RPS6KA2 | 0.33995787 |
| 119 | STK24 | 0.32854287 |
| 120 | PRKCQ | 0.32523153 |
| 121 | RET | 0.31740040 |
| 122 | STK11 | 0.31487041 |
| 123 | STK38 | 0.31193841 |
| 124 | TAOK1 | 0.31127684 |
| 125 | MAPK12 | 0.30877219 |
| 126 | WEE1 | 0.30870897 |
| 127 | PRKCD | 0.30792496 |
| 128 | MAP3K6 | 0.30113072 |
| 129 | MAP2K6 | 0.29987897 |
| 130 | ATR | 0.29907199 |
| 131 | ALK | 0.29288184 |
| 132 | EGFR | 0.28816768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.05088975 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.85422328 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.43174425 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.41389236 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35012986 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20242545 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.14564042 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.13023048 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.12140743 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.03558366 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98380220 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96423028 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.92205268 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89788695 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81681934 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76537992 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72699120 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71513437 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.64079989 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.63465705 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.63319229 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61283573 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60737519 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59184912 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56972678 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53542191 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.52808355 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.51850069 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48460136 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.47545191 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.43841894 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43399161 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.42721216 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.42658692 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41290293 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.36651884 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.34547353 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33192360 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32827214 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31235393 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29234301 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.23291402 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21362810 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20427214 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.19729571 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17619023 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16275118 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13768626 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.13187023 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08380271 |
| 51 | Base excision repair_Homo sapiens_hsa03410 | 1.07149481 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05423692 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.01635886 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96094894 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95651100 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89581557 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89224949 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85996797 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82676305 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.82650438 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.78818080 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78396629 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78273524 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.77297540 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76935851 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76841481 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.76108907 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75135339 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73159122 |
| 70 | Homologous recombination_Homo sapiens_hsa03440 | 0.71816005 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71411849 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70124532 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68051286 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68051029 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.67154805 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64493707 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64405998 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61966226 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57016409 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56157488 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55198582 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54768469 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54544816 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54295489 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.53754128 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.53345122 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.53253732 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51392673 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.50848617 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50089722 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49954304 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49613139 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48957648 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.48589636 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48279990 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48037817 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47340319 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47227830 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46937180 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46628830 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45705586 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45615512 |
| 103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45557166 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44344234 |
| 105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44199788 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43360815 |
| 107 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.42184924 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41720627 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41370213 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39912898 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.38042949 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37583329 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.36650850 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35756882 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35423280 |
| 116 | Cell cycle_Homo sapiens_hsa04110 | 0.34946643 |
| 117 | Spliceosome_Homo sapiens_hsa03040 | 0.33409844 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33224520 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33052336 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32280137 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31458239 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.31321411 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30188819 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30137094 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28531615 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28021488 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.26595842 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.26593277 |

